Atorolimumab
| Monoclonal antibody | |
|---|---|
| Type | Whole antibody |
| Source | Human |
| Target | RhD |
| Clinical data | |
| ATC code | none |
| Identifiers | |
| CAS Number |
202833-08-7  N |
| ChemSpider | none |
N Y (what is this?) (verify) | |
Atorolimumab is an immunosuppressive drug directed against the Rhesus factor.[1]
References
| Intracellular (initiation) |
| ||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Intracellular (reception) |
| ||||||||||||||||||||||
| Extracellular |
| ||||||||||||||||||||||
This article is issued from Wikipedia - version of the 8/13/2016. The text is available under the Creative Commons Attribution/Share Alike but additional terms may apply for the media files.